CLINICAL_TRIALS
trial_result
· 2020-09-03
Clinical Trial Update: A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors [Phase 1]
Summary
Phase 1 trial update for RO7172508 in CEA-positive solid tumors; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2020-09-03